Renault-Nissan's workers at its car plant in Tamil Nadu, southern India will go on strike today for the failure of the company to meet their COVID-related safety demands.
The strike threat comes ahead of a court hearing over workers' allegations that social distancing norms were being flouted and factory health policies did not sufficiently address the risk to lives.
The union, which represents around 3,500 workers at the plant, added they would not return until they felt safe.
Nissan, which owns a majority stake in the plant, declined to comment, saying the matter was in court.
Renault-Nissan rejected workers' allegations before an Indian court last week, adding it needed to continue production to meet orders.
Tamil Nadu, an auto hub known as India's Detroit, has over 30,000 COVID-19 cases a day.
The state is under a lockdown until May 31 but some factories, including auto plants, continue to operate.


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 



